Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Biocon Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532523
ISIN Demat	INE376G01013
Book Value	119.86

NSE Code	BIOCON
Dividend Yield %	0.14
Market Cap	484983.56

P/E	79.60
EPS	4.56
Face Value	5


	BSE		NSE

01-Jul-2025 15:30

Last Price	362.70
Net Change	7.1
% Change	2%
Prev.Close	355.60
Open	356.05
High	363.20
Low	354.15
Volume	156005

Last Price	362.05
Net Change	6.35
% Change	1.79%
Prev.Close	355.70
Open	356.00
High	363.45
Low	354.00
Volume	5124105

Value	56583013.5
Best Buy	362.00
Best Sell	363.00
Best Quantity	15
Sell Quantity	100
Today's Range	363.20
52-Week High	404.60
52-Week Low	290.80

Value	1855182215.25
Best Buy	362.05
Best Sell	362.30
Best Quantity	959
Sell Quantity	4592
Today's Range	363.45
52-Week High	404.70
52-Week Low	291.00

Open Price	358.30
High Price	364.95
Low Price	355.60
Last Price	364.20
Prev Close	357.55
Change	6.65
% Change	1.86 %

Average Price	361.03
Underlying Value	362.05
Number of contracts traded	5740
Turnover in Rs. Lakhs	51808
Open Interest	39267500.00
Change in O I	2912500.00
% Change in O I	8.01 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	15
Price	362.00

Quantity	100
Price	363.00

Best Bid

Best Offer

Quantity	959
Price	362.05

Quantity	4592
Price	362.30

Best Bid

Best Offer

Quantity	5000
Price	364.1

Quantity	7500
Price	364.35

Holding Details

Latest Corporate Events

Bonus

1 : 1

12-Jun-19

Book Closure

22-Jul-17

28-Jul-17

Dividend

10 %

04-Jul-25

Company News

30-06-2025

Biocon’s arm expands insu...

30-06-2025

Biocon informs about pres...

27-06-2025

Biocon’s arm receives NOC...

27-06-2025

Biocon informs about pre...

27-06-2025

Biocon moves up as its ar...

26-06-2025

Biocon informs about comm...

26-06-2025

Substantial Acquisition o...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.